POMC, PCSK1, and LEPR Deficiency and BBS (Pediatric Patients Aged 2 to less than 6 Years) The safety of IMCIVREE was evaluated in one 52-week, open-label clinical trial of 12 patients aged 2 to less than 6 years with obesity due to POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPRgenes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance, or obesity due to BBS (Trial 5) [see Clinical Studies (14.4)]
Many people need a family member, friend, or caregiver to help since its hard to reach on your own
Head-to-Head Comparison: BPC-157 vs IGF-1 for Mens Health Goals Choosing between BPC-157 and IGF-1 ultimately depends on your specific health goals and current challenges
DISCLAIMER: The content in this article is intended for informational purposes only